Venture Capital Investors

Intersouth Partners

Intersouth Partners makes VC investments in techn-focused companies.

Venture Investor Overview

Venture Investor
Intersouth Partners
Status
Active
Investor Type
Venture Capital
Activity Level
142 transactions
Funds Raised
At least $478.2 million
Industry Focus
Medical Devices & Instruments

Contact Information

Contact
Dennis Dougherty
Title
Founding Partner
Mailing Address
4711 Hope Valley Rd. 4F - 632
Durham, NC 27707
USA
Phone
(919) 493-6640
Website
www.intersouth.com
Email Address
Not Recorded

Background Information

Overview
Based in Durham, North Carolina, Intersouth Partners seeks a broad range of investment opportunities in the technology and life science sectors. Our experienced team has full-cycle experience in the complex matters associated with investing in fledgling companies, including technology assessment and transfer, management team development, corporate partnering, sales growth and successful exits.
Profile
Intersouth Partners LinkedIn Company Profile
Social Media
Intersouth Partners Company Twitter Account
Company News
Intersouth Partners News
Facebook
Intersouth Partners on Facebook
YouTube
Intersouth Partners on YouTube
Last Transaction
9/9/2024

Transaction History

Our records indicate that Intersouth Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
CSA Medical
9/9/2024
$53,000,000
CSA Medical
10/10/2018
$23,000,000
Lyra Therapeutics
9/27/2018
$29,500,000
Azalea Health
7/18/2016
$10,500,000
Advanced Animal Diagnostics
3/31/2016
$1,716,000
480 Biomedical
6/3/2015
$10,500,000
Arsenal Medical
6/2/2015
$16,000,000
Innocrin
4/16/2015
$28,000,000
Technocom
3/31/2015
$1,290,000
Azalea Health
3/31/2015
$1,500,000
Advanced Animal Diagnostics
12/9/2014
$15,000,000
Viamet Pharmaceuticals
10/21/2014
$60,000,000
Proteon Therapeutics
5/16/2014
$45,000,000
simplifyMD
12/31/2013
$500,000
Viamet Pharmaceuticals
12/31/2013
$5,000,000
CSA Medical
12/23/2013
$16,000,000
PeopleMatter
10/28/2013
$16,000,000
Argos Therapeutics
8/26/2013
$42,500,000
AGTC
6/30/2013
$9,621,000
Advanced Animal Diagnostics
4/11/2013
$6,000,000
480 Biomedical
3/31/2013
$21,200,000
nContact Surgical
3/31/2013
$6,736,000
PeopleMatter
3/4/2013
$19,000,000
Row Sham Bow
12/31/2012
$3,040,000
Viamet Pharmaceuticals
12/31/2012
$3,000,100
AGTC
11/21/2012
$37,500,000
Zenoss
10/9/2012
$25,000,000
Vascular Pharmaceuticals
9/13/2012
$16,000,000
ABT Molecular Imaging
9/11/2012
$6,053,150
MicroCHIPS
6/30/2012
$750,000
Esanex
6/30/2012
$5,000,000
Argos Therapeutics
4/24/2012
$25,000,000
Adaptivity
3/31/2012
$3,000,000
Semprius
3/29/2012
$7,500,000
PeopleMatter
2/27/2012
$14,000,000
Vergent Medical Systems
12/31/2011
$6,200,000
CSA Medical
12/15/2011
$20,500,000
simplifyMD
11/15/2011
$4,500,000
Arsenal Medical
9/30/2011
$18,300,000
Adaptivity
9/20/2011
$6,000,000
6fusion
8/22/2011
$7,000,000
Semprius
6/29/2011
$20,000,000
Row Sham Bow
5/9/2011
$3,000,000
PeopleMatter
5/5/2011
$7,200,000
RedCloud
3/17/2011
$3,420,000
Advanced Animal Diagnostics
3/16/2011
$11,000,000
Adaptivity
10/5/2010
$7,200,000
Calibra Medical
9/30/2010
$2,000,000
New River Innovation
9/30/2010
$2,000,000
Ziptronix
9/30/2010
$1,500,000
CallMiner
9/1/2010
$4,000,000
6fusion
8/23/2010
$3,000,000
Mixx
6/30/2010
$600,000
Cempra
6/30/2010
$20,499,900
Flatburger
6/30/2010
$710,000
Overture Networks
4/22/2010
$17,200,000
CancerGuide Diagnostics
1/28/2010
$10,500,000
MicroCHIPS
1/7/2010
$16,500,000
New River Innovation
12/31/2009
$2,000,000
Calibra Medical
11/24/2009
$1,400,000
Zenph Studios
11/13/2009
$10,700,000
TransEnterix
10/7/2009
$55,000,000
Alimera Sciences
9/30/2009
$5,000,000
ABT Molecular Imaging
9/30/2009
$6,000,000
SiXis
9/29/2009
$3,000,000
Acadia Human Capital Solutions
9/16/2009
$5,000,000
Mixx
6/30/2009
$4,000,000
Semprius
6/9/2009
$6,400,000
Cempra
5/14/2009
$46,000,000
AGTC
5/1/2009
$11,800,000
Bright View Technologies
4/21/2009
$4,000,000
Flatburger
3/31/2009
$1,000,000
MicroCHIPS
3/31/2009
$18,000,000
Argolyn Bioscience
3/31/2009
$2,000,000
CallMiner
3/18/2009
Unknown
Proteon Therapeutics
3/5/2009
$38,000,000
LOC-AID Technologies
12/31/2008
$8,152,000
Argos Therapeutics
11/24/2008
$35,200,000
Biolex
10/6/2008
$60,000,000
Viamet Pharmaceuticals
9/30/2008
$3,025,000
NovaMin Technology
9/30/2008
$5,000,000
Purewire
9/25/2008
$1,000,000
Clarabridge
8/11/2008
$12,000,000
Athenix
7/22/2008
$10,000,000
Nitronex
6/30/2008
$7,500,000
SiXis
6/9/2008
$5,000,000
Aldagen
4/24/2008
$18,400,000
Alimera Sciences
3/18/2008
$30,000,000
Mixx
2/25/2008
$2,000,000
Zenoss
1/21/2008
$11,000,000
NovaMin Technology
1/14/2008
$2,500,000
Cempra
1/14/2008
$10,000,000
Viamet Pharmaceuticals
12/31/2007
$1,000,000
Trinity Convergence
12/23/2007
$12,650,000
WWR Biomedical
10/1/2007
$13,100,000
Overture Networks
9/27/2007
$12,300,000
Aldagen
9/13/2007
$9,000,000
AGTC
6/30/2007
$12,550,200
Serenex
6/28/2007
$31,000,000
Argolyn Bioscience
6/25/2007
$15,800,000
Mixx
6/19/2007
$1,550,000
Viamet Pharmaceuticals
6/7/2007
$4,000,000
Biolex
5/24/2007
$30,000,000
Flatburger
5/17/2007
$5,000,000
Semprius
4/16/2007
$4,100,000
Defywire
4/9/2007
$2,800,000
Proteon Therapeutics
4/6/2007
$12,000,000
MicroCHIPS
4/3/2007
$13,400,000
Rally Software
1/31/2007
$5,000,000
Clarabridge
1/23/2007
$7,200,000
Invistics
12/31/2006
$1,199,900
Aldagen
12/19/2006
$17,300,000
Alimera Sciences
11/28/2006
$15,900,000
Jacket Micro Devices
10/6/2006
$12,000,000
Cempra
9/30/2006
$14,000,000
Covega
8/21/2006
$10,000,000
Zenoss
8/11/2006
$4,800,000
CallMiner
6/30/2006
$10,000,000
Nitronex
6/19/2006
$21,800,000
Overture Services
6/1/2006
$7,500,000
KAI Pharmaceuticals
5/2/2006
$35,000,000
Workspace.com
3/31/2006
$1,075,000
Proteon Therapeutics
3/30/2006
$19,000,000
Athenix
1/6/2006
$13,000,000
Alimera Sciences
12/1/2005
$31,800,000
HexaTech
11/30/2005
$8,900,000
Serenex
10/3/2005
$30,000,000
Biolex
9/1/2005
$36,000,000
Ziptronix
8/12/2005
$7,200,000
NovaMin Technology
6/30/2005
$4,400,000
Defywire
6/30/2005
$3,600,000
CallMiner
3/31/2005
$2,799,900
Covega
3/31/2005
$5,464,000
Trinity Convergence
12/31/2004
$5,600,000
Serenex
8/3/2004
$8,000,000
Alimera Sciences
7/9/2004
$26,750,000
Athenix
1/20/2004
$12,500,000
KAI Pharmaceuticals
12/3/2003
$17,000,000
Biolex
8/20/2003
$24,400,000
Defywire
6/5/2003
$4,500,000
Ziptronix
6/3/2003
$17,400,000
Codeon
3/5/2003
$17,000,000

 

Investor Contacts

Title
Name
Email & Social
Founding Partner
Dennis Dougherty
  Dennis Dougherty LinkedIn Profile  Dennis Dougherty Twitter Account  Dennis Dougherty News  Dennis Dougherty on Facebook
Partner
John Glushik
  John Glushik LinkedIn Profile  John Glushik Twitter Account  John Glushik News  John Glushik on Facebook
Partner
Richard Kent
  Richard Kent LinkedIn Profile  Richard Kent Twitter Account  Richard Kent News  Richard Kent on Facebook
Partner
Mitch Mumma
  Mitch Mumma LinkedIn Profile  Mitch Mumma Twitter Account  Mitch Mumma News  Mitch Mumma on Facebook

 

Funds

Our database includes the following fund closing(s) for Intersouth Partners. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
InterSouth Partners VII
5/25/2006
$275,000,000
InterSouth Partners VI
3/3/2003
$203,225,000

 

Portfolio Companies

Intersouth Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
480 Biomedical
6fusion
ABT Molecular Imaging
Acadia Human Capital Solutions
Adaptivity
Advanced Animal Diagnostics
AGTC
Aldagen
Alimera Sciences
Argolyn Bioscience
Argos Therapeutics
Arsenal Medical
Athenix
Azalea Health
Biolex
Bright View Technologies
Calibra Medical
CallMiner
CancerGuide Diagnostics
Cempra
Clarabridge
Codeon
Covega
CSA Medical
Defywire
Esanex
Flatburger
HexaTech
Innocrin
Invistics
Jacket Micro Devices
KAI Pharmaceuticals
LOC-AID Technologies
Lyra Therapeutics
MicroCHIPS
Mixx
nContact Surgical
New River Innovation
Nitronex
NovaMin Technology
Overture Networks
Overture Services
PeopleMatter
Proteon Therapeutics
Purewire
Rally Software
RedCloud
Row Sham Bow
Semprius
Serenex
simplifyMD
SiXis
Technocom
TransEnterix
Trinity Convergence
Vascular Pharmaceuticals
Vergent Medical Systems
Viamet Pharmaceuticals
Workspace.com
WWR Biomedical
Zenoss
Zenph Studios
Ziptronix

 

 

 

 

Browse more venture capital investors:

Intersection Fintech Ventures | Interswitch

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.